X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
63
PharmaCompass offers a list of Travoprost API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Travoprost manufacturer or Travoprost supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Travoprost manufacturer or Travoprost supplier.
PharmaCompass also assists you with knowing the Travoprost API Price utilized in the formulation of products. Travoprost API Price is not always fixed or binding as the Travoprost Price is obtained through a variety of data sources. The Travoprost Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Travoprost manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Travoprost, including repackagers and relabelers. The FDA regulates Travoprost manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Travoprost API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Travoprost manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Travoprost supplier is an individual or a company that provides Travoprost active pharmaceutical ingredient (API) or Travoprost finished formulations upon request. The Travoprost suppliers may include Travoprost API manufacturers, exporters, distributors and traders.
click here to find a list of Travoprost suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Travoprost DMF (Drug Master File) is a document detailing the whole manufacturing process of Travoprost active pharmaceutical ingredient (API) in detail. Different forms of Travoprost DMFs exist exist since differing nations have different regulations, such as Travoprost USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Travoprost DMF submitted to regulatory agencies in the US is known as a USDMF. Travoprost USDMF includes data on Travoprost's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Travoprost USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Travoprost suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Travoprost Drug Master File in Japan (Travoprost JDMF) empowers Travoprost API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Travoprost JDMF during the approval evaluation for pharmaceutical products. At the time of Travoprost JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Travoprost suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Travoprost Drug Master File in Korea (Travoprost KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Travoprost. The MFDS reviews the Travoprost KDMF as part of the drug registration process and uses the information provided in the Travoprost KDMF to evaluate the safety and efficacy of the drug.
After submitting a Travoprost KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Travoprost API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Travoprost suppliers with KDMF on PharmaCompass.
A Travoprost written confirmation (Travoprost WC) is an official document issued by a regulatory agency to a Travoprost manufacturer, verifying that the manufacturing facility of a Travoprost active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Travoprost APIs or Travoprost finished pharmaceutical products to another nation, regulatory agencies frequently require a Travoprost WC (written confirmation) as part of the regulatory process.
click here to find a list of Travoprost suppliers with Written Confirmation (WC) on PharmaCompass.
Travoprost Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Travoprost GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Travoprost GMP manufacturer or Travoprost GMP API supplier for your needs.
A Travoprost CoA (Certificate of Analysis) is a formal document that attests to Travoprost's compliance with Travoprost specifications and serves as a tool for batch-level quality control.
Travoprost CoA mostly includes findings from lab analyses of a specific batch. For each Travoprost CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Travoprost may be tested according to a variety of international standards, such as European Pharmacopoeia (Travoprost EP), Travoprost JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Travoprost USP).
Market Place
